Wall Street Says Disney Should Still Be a Winning Stock

Disney's dive after earnings could open up a buying opportunity to investors that missed the recent run.

Tyson Foods Doesn't Turn Tail in Perilous Market After Earnings

The food giant is one of the few stocks holding its ground on Monday morning; here's why.

Interest Lights Up in CannTrust After Talks of Going on the Block

Following growing scandal, CannTrust Holdings is luring bargain shoppers as the stock moves higher after the company announced it's considering selling itself.

What's the Impact of Apple's Intel Deal on Its 5G Plan?

Apple has investors and analysts looking forward to its the 5G future.

While No Magic Pill, Mylan Deal Might Just Revive Drugmaker

The merger with Pfizer's off-patent branded medicines business may be a life-preserver for bulls and provide meaningful expansion across geographical regions while leveraging Pfizer's commercialization capabilities.

Pfizer Deal Might Be Good Treatment for Mylan

But this off-patent tie-up comes with some questions -- such as why are so many Mylan executives hanging on?

A Look at Mylan's New Post-Merger Management

What new management means for Mylan shareholders moving forward.

Mylan Jumps on Deal With Pfizer to Form New Company

Pfizer will combine its off-patent drug business with Mylan in the as-yet-to-be-named new company.

Earnings Volcano Erupts, Locking In on Lam, and Apple-Intel Intel: Market Recon

Also, defense industry names can breathe easier with word of debt ceiling and federal spending deal.

Give Credit to Blue Apron for Partnering With Beyond Meat

The issue is whether it will inspire longer-term customer relationships.